S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Atea Pharmaceuticals (AVIR) Insider Trading & Ownership

$3.70
-0.01 (-0.27%)
(As of 04/18/2024 ET)

Atea Pharmaceuticals (NASDAQ:AVIR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
14.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$327,852.30
Get AVIR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Atea Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AVIR Insider Buying and Selling by Quarter

Atea Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/1/2024Andrea CorcoranInsiderSell15,843$3.84$60,837.12  
2/1/2024Jean-Pierre SommadossiCEOSell56,910$3.85$219,103.50  
2/1/2024Wayne FosterCAOSell12,477$3.84$47,911.68  
(Data available from 1/1/2013 forward)

AVIR Insider Trading Activity - Frequently Asked Questions

Who is on Atea Pharmaceuticals's Insider Roster?

The list of insiders at Atea Pharmaceuticals includes Andrea Corcoran, Franklin M Berger, Jean-Pierre Sommadossi, Polly A Murphy, and Wayne Foster. Learn more on insiders at AVIR.

What percentage of Atea Pharmaceuticals stock is owned by insiders?

14.50% of Atea Pharmaceuticals stock is owned by insiders. Learn more on AVIR's insider holdings.

Which Atea Pharmaceuticals insiders have been selling company stock?

The following insiders have sold AVIR shares in the last 24 months: Andrea Corcoran ($60,837.12), Franklin M Berger ($214,741.56), Jean-Pierre Sommadossi ($219,103.50), and Wayne Foster ($47,911.68).

How much insider selling is happening at Atea Pharmaceuticals?

Insiders have sold a total of 126,896 Atea Pharmaceuticals shares in the last 24 months for a total of $542,593.86 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:AVIR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners